Pilot Study of SBRT and CDX-1127 in Prostate Cancer

Stopped early · Phase 1

Conditions studied: Prostatic Neoplasms, Prostate Cancer

In brief

This study evaluates the combination of stereotactic body radiation therapy (SBRT) and CDX-1127 in subjects with castration resistant prostate cancer. Subjects will be randomized to one of three arms to receive SBRT prior to, after, or in conjunction with the first dose of CDX-1127.

Key facts

Study ID

NCT02284971

Run by

James Larner, MD

People needed

2

Starts

2014-11-01

Expected to finish

2016-04-07

Last updated by the study team

2018-05-17

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• University of Virginia — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.